Meridian Wealth Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15,000
| Closed | -$154K | – | 557 |
|
|
2022
Q4 | $154K | Sell |
15,000
-12,000
| -44% | -$123K | 0.02% | 500 |
|
|
2022
Q3 | $210K | Hold |
27,000
| – | – | 0.02% | 448 |
|
|
2022
Q2 | $142K | Sell |
27,000
-15,094
| -36% | -$79.4K | 0.01% | 526 |
|
|
2022
Q1 | $467K | Hold |
42,094
| – | – | 0.05% | 249 |
|
|
2021
Q4 | $416K | Hold |
42,094
| – | – | 0.04% | 265 |
|
|
2021
Q3 | $415K | Buy |
42,094
+15,094
| +56% | +$149K | 0.05% | 249 |
|
|
2021
Q2 | $279K | Buy |
27,000
+8,100
| +43% | +$83.7K | 0.04% | 315 |
|
|
2021
Q1 | $193K | Buy |
+18,900
| New | +$193K | 0.03% | 352 |
|